Latest filing published 01 Sept 2025 for 達邦蛋白.
No signal scores available.
劉郁芬 discloses dealings in 達邦蛋白 to TWSE / TPEx (MOPS). We count 2 filings; the first trade dates from 7 September 2020 and the latest from 1 September 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 1 September 2025 came the latest disclosure, a transaction in 達邦蛋白. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.